Skip to main content

and
  1. No Access

    Article

    HLA associations with infliximab-induced liver injury

    Biomarkers that are able to identify patients at risk of drug-induced liver injury (DILI) after treatment with infliximab could be important in increasing the safety of infliximab use. We performed a genetic a...

    Christopher D. Bruno, Brandon Fremd, Rachel J. Church in The Pharmacogenomics Journal (2020)